TY - JOUR
KW - Adult
KW - Analgesics, Opioid/therapeutic use
KW - Delayed-Action Preparations/therapeutic use
KW - Humans
KW - Injections, Intramuscular
KW - Male
KW - Naltrexone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - Opioid-Related Disorders/drug therapy
KW - Recurrence
KW - treatment adherence and compliance
KW - Adherence to treatment
KW - Extended-release naltrexone
KW - opioid maintenance treatment
KW - Relapse risk
KW - Treatment Preference
AU - Z. Gaulen
AU - I. H. Brenna
AU - L. T. Fadnes
AU - Šaltytė Benth
AU - K. K. Solli
AU - N. Kunoe
AU - A. Opheim
AU - L. Tanum
A1 - 
AD - Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Dentistry, University of Bergen, Bergen, Norway.; Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Psychology, University of Bergen, Bergen, Norway.; Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.; Institute of Clinical Medicine, Campus Ahus, University of Oslo, Blindern, Norway.; Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway.; Department of Research and Development in Mental Health, Akershus University Hospital, Lørenskog, Norway.; Norwegian Center for Addiction Research, University of Oslo, Oslo, Norway.; Vestfold Hospital Trust, Tonsberg, Norway.; Norwegian Center for Addiction Research, University of Oslo, Oslo, Norway.; Lovisenberg Diaconal Hospital, Oslo, Norway.; Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.; Department of Research and Development in Mental Health, Akershus University Hospital, Lørenskog, Norway.; Department of Health Science, Oslo Metropolitan University, Oslo, Norway.
BT - European addiction research
C5 - Opioids & Substance Use
CP - 1
CY - Switzerland
DO - 10.1159/000518436
IS - 1
JF - European addiction research
LA - eng
M1 - Journal Article
PB - S. Karger AG, Basel
PP - Switzerland
PY - 2022
SN - 1421-9891; 1022-6877
SP - 56
EP - 67
EP - 
T1 - The Predictive Value of Degree of Preference for Extended-Release Naltrexone for Treatment Adherence, Opioid Use, and Relapse
T2 - European addiction research
TI - The Predictive Value of Degree of Preference for Extended-Release Naltrexone for Treatment Adherence, Opioid Use, and Relapse
U1 - Opioids & Substance Use
U2 - 34569487
U3 - 10.1159/000518436
VL - 28
VO - 1421-9891; 1022-6877
Y1 - 2022
ER -